Hyperprolactinemia in males with systemic lupus erythematosus

Journal of Rheumatology

Volumn 25, Issue 12, 1998, Pages 2357-2363

  Mok, Chi Chiu ^a   Lau, Chak Sing ^a   Lee, Ka Wing ^a   Wong, Raymond Woon Sing ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Men; Prolactin; Sex hormones; SLE

Indexed keywords

DNA ANTIBODY; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERPROLACTINEMIA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; COMPLEMENT C3; COMPLEMENT C4; HUMANS; HYPERPROLACTINEMIA; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROLACTIN; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0002771243     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wallace DJ. The clinical presentation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus, 5th ed. Baltimore: William & Wilkins; 1997:627-33.
2. Talal N, Ahmed SA. Immunomodulation by hormones - an area of growing importance [editorial]. J Rheumatol 1987;14:191-3.
3. Inman RD, Jovanovic L, Markenson JA, et al. Systemic lupus erythematosus in men: genetic and endocrine features. Arch Intern Med 1982;142:1813-5.
4. Talal N. Sex steroid hormones and systemic lupus erythematosus. Arthritis Rheum 1981;24:1054-6.
5. Lavalle C, Loyo E, Paniagna R, et al. Correlation study between prolactin and androgen in male patients with SLE. J Rheumatol 1987;14:268-72.
6. Sequeira JF, Keser G, Greenstein B, et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993;2:315-7.
7. Lahita RG, Bradlow HL. Klinefelter's syndrome. Hormonal metabolism in hypogonadal males with systemic lupus erythematosus. J Rheumatol 1987;14 Suppl 13:154-7.
8. French MAH, Hughes P. Systemic lupus erythematosus and Klinefelter's syndrome. Ann Rheum Dis 1983;42:471-3.
9. Jara JL, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? [editorial]. J Rheumatol 1992;19:1333-6.
10. McMurray RW, Keisler D, Izui S, Walker SE. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994;71:338-43.
11. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in female B/W mouse. J Immunol 1991;147:3780-7.
12. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol 1993;20:1143-51.
13. Walker SE, Allen SH, Hoffmann RW, McMurray RW. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 1995;4:3-9.
14. Folomeev M, Prokaeva T, Nassonova V, Nassonov E, Masenko V, Ovtraht N. Prolactin levels in men with systemic lupus erythematosus and rheumatoid arthritis [letter]. J Rheumatol 1990;17:1569-70.
15. Jara LJ, Gomez-Sanchez C, Silveria LH, Martinez-Osuna P, Vasey FB, Espinosa LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease. Am J Med Sci 1992;303:222-6.
16. Pauzner R, Urowitz MR, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus. J Rheumatol 1994;11:2064-7.
17. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.
18. Ostendorf B, Fischer R, Santen R, Schmitz-Linneweber B, Specker C, Schneider M. Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996;25:97-102.
19. Mok CC, Lau CS, Tam SCF. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br J Rheumatol 1997;36:986-9.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
22. Berczi I. The immunology of prolactin. Semin Reprod Endocrinol 1992;10:196-219.
23. Nagy E, Berczi I. Immunodeficiency in hypophysectomised rats. Acta Endocrinol (Copenh) 1978;89:530-7.
24. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology 1983;6:231-43.
25. Russell DH, Matrisian L, Kibler R, et al. Prolactin receptors on human lymphocytes and their modulation by cyclosporin. Biochem Biophys Res Commun 1984;121:899-906.
26. Mukherjee P, Mastro AM, Hymer WC. Prolactin induction of IL-2 receptors on rat splenic lymphocytes. Endocrinology 1990;126:88-94.
27. Viselli SM, Stanek EM, Mukherjee P, Hymer WC, Mastro AM. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 1991;129:983-90.
28. Spangelo BL, Hall NRS, Ross PC, Goldstein AL. Stimulation of in-vitro antibody production and concanavalin-A induced mouse spleen cell mitogenesis by prolactin. Int J Immunopharmacol 1987;14:11-20.
29. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE. Prolactin receptors on human B and T lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 1985;134:3027-31.
30. Gutierrez MA, Molina JF, Jara LJ, et al. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 1996;109:229-35.
31. Hartmann DP, Holaday JU, Bernton EW. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 1989;3:2194-202.
32. Whyte A, Williams RO. Bromocriptine treatment suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988;31:927-8.
33. Palestine AG, Muellenberg-Coulombre CG, Kim MK, et al. Bromocriptine and low dose cyclosporine in the treatment of experimental uveitis in the rat. J Clin Invest 1987;79:1076-81.
34. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994;21:843-50.
35. McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995;22:2084-91.
36. El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and central nervous system manifestations. J Rheumatol 1996;23:374-7.
37. Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology 1992;131:3019-26.
38. Sabharwal P, Glaser R, Lafuse W, et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 1992;89:7713-6.
39. Larrea F, Martinez-Castillo A, Cabrera V, et al. A bioactive 60-kD prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab 1997;82:3664-9.
40. Al-Janadi M, Al-Bella S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 1993;13:58-67.
41. Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067-74.
42. Stuart RA, Littlewood AJ, Maddison PJ, Hall ND. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin Exp Rheumatol 1995;13:17-22.
43. Steger RW, Silverman AY, Asch RH. Glucocorticoid suppression of pituitary prolactin release in the nonhuman primate. J Clin Endocrinol Metab 1981;6:1167-70.
44. Conconi M, Walker AM. Chloroquine affects prolactin secretion and golgi morphology in the mammotroph. Endocrinology 1984;114:725-34.